V 590
Alternative Names: Coronavirus vaccine - International AIDS Vaccine Initiative/Merck & Co; COVID-19 Vaccine - International AIDS Vaccine Initiative/Merck Sharp & Dohme; SARS-CoV-2 vaccine - International AIDS Vaccine Initiative/Merck & Co; V-590Latest Information Update: 02 Oct 2021
At a glance
- Originator International AIDS Vaccine Initiative
- Developer International AIDS Vaccine Initiative; Merck Sharp & Dohme
- Class COVID-19 vaccines; Synthetic vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued COVID 2019 infections